KeyBank National Association
AMPE

KeyBank National Association’s Ampio Pharmaceuticals Inc. AMPE Stock Holding History

KeyBank National Association’s Portfolio AMPE Stock Details AMPE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q2 		– Sell
-233
Closed -$56K – 1157
2017
Q1 		$56K Sell
233
-12
-5% -$3.23K ﹤0.01% 1129
2016
Q4 		$66K Buy
245
+33
+16% +$7.86K ﹤0.01% 1129
2016
Q3 		$47K Hold
212
– – ﹤0.01% 1141
2016
Q2 		$82K Buy
+212
New +$232K ﹤0.01% 1087
2014
Q1 		– Sell
-703
Closed -$1.5M – 1305
2013
Q4 		$1.5M Buy
703
+20
+3% +$47.3K 0.01% 506
2013
Q3 		$1.54M Hold
683
– – 0.01% 484
2013
Q2 		$1.18M Buy
+683
New +$1.08M ﹤0.01% 748

Other funds holding AMPE

KCM
Knoll Capital Management Miami, Florida $180M AUM 66.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $432B AUM 29.4% 1-Year Est. Return
ECM
Element Capital Management New York $1.05B AUM 5.05% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
NFG
Noven Financial Group Denver, Colorado $123M AUM 5.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return

KeyBank National Association's AMPE Position: Q2 2017 in Review

KeyBank National Association sold out of Ampio Pharmaceuticals Inc. (AMPE) in Q2 2017, closing a stake of 233 shares — an estimated $56K sold.

KeyBank National Association first reported a position in AMPE in Q2 2013 and held it in 7 quarters. The position peaked at $1.54M in Q3 2013. 56 funds tracked by Wall St. Rank hold AMPE as of Q2 2017.

  • KeyBank National Association reported no remaining Ampio Pharmaceuticals Inc. position as of Q2 2017 after selling out during the quarter.
  • KeyBank National Association sold 233 Ampio Pharmaceuticals Inc. shares in Q2 2017, an estimated $56K.
  • KeyBank National Association first reported a position in Ampio Pharmaceuticals Inc. in Q2 2013 and held it in 7 quarters.
  • KeyBank National Association's Ampio Pharmaceuticals Inc. position peaked at $1.54M in Q3 2013.
  • 56 funds tracked by Wall St. Rank held Ampio Pharmaceuticals Inc. as of Q2 2017.

Based on KeyBank National Association's 13F filing for Q2 2017, filed 8 Aug 2017.